Compare DRTS & ECVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRTS | ECVT |
|---|---|---|
| Founded | 2015 | 1935 |
| Country | Israel | United States |
| Employees | N/A | 617 |
| Industry | Medical/Dental Instruments | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.1B |
| IPO Year | 2021 | 2017 |
| Metric | DRTS | ECVT |
|---|---|---|
| Price | $13.21 | $10.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $17.80 | $15.17 |
| AVG Volume (30 Days) | 432.5K | ★ 1.0M |
| Earning Date | 11-19-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $723,515,000.00 |
| Revenue This Year | N/A | $44.46 |
| Revenue Next Year | $1,235.59 | $2.81 |
| P/E Ratio | ★ N/A | $92.45 |
| Revenue Growth | N/A | ★ 2.70 |
| 52 Week Low | $3.43 | $7.41 |
| 52 Week High | $15.79 | $15.09 |
| Indicator | DRTS | ECVT |
|---|---|---|
| Relative Strength Index (RSI) | 35.13 | 47.87 |
| Support Level | $11.51 | $9.77 |
| Resistance Level | $14.00 | $10.57 |
| Average True Range (ATR) | 0.51 | 0.24 |
| MACD | -0.19 | 0.01 |
| Stochastic Oscillator | 5.18 | 60.64 |
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has one operating segment. The Company's single reportable segment, Ecoservices, derives its revenue through the sale of virgin and regenerated sulfuric acid products and services.